Last reviewed · How we verify

NCT00682968

Evidence Synthesis: Hypertension Medication Adherence & Intensification

Completed Last updated 6 June 2017
What this trial tests

trial in Hypertension in 20 participants. Completed in 1 October 2008.

Timeline
20 July 2008
Primary endpoint
30 September 2008
1 October 2008

Quick facts

Lead sponsorVA Office of Research and Development
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date20 July 2008
Primary completion30 September 2008
Estimated completion1 October 2008
Sites1 location across United States

Conditions studied

Sponsor

VA Office of Research and Development — full company profile →

Who can join

Eligibility, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hypertension affects nearly 50 million Americans \[1\] and is the most common chronic condition among veterans. Unfortunately, many patients with established hypertension have poorly controlled blood pressure (BP); control rates in the VA are at approximately 70% currently. While clinician failure to aggressively manage hypertension through therapeutic intensification (clinical inertia, or failure to intensify pharmacotherapy appropriately) contributes to poor blood pressure control, even when doctors do intensify therapy, 43-78% of patients fail to adhere to recommended therapies, indicating that adherence remains a central problem in hypertension care. This suggests important opportunities for interventions to improve risk factor control by working through clinicians, their teams, or their delivery systems, as well as with patients, to address both patient adherence and clinical inertia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other VA Office of Research and Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00682968.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing